 1. Select breast center patients who consent to participate in this study will take a basic familialgenetic risk survey that follows NCCN guidelines up to 2,000 patients will be consented into this study, with a sub-cohort of up to 300 who are identified to have a familial genetic risk for breast cancer. If no risk is identified, the patient is not specifically informed of genetic counseling. 